Kidney transplant with positive SARS-CoV-2 PCR: An avoidable risk.
作者信息
Villanego Florentino, Vigara Luis Alberto, Montero María Elisa, García Teresa, Peñate-Garrido Juan Manuel, Mazuecos Auxiliadora
机构信息
Department of Nephrology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Department of Microbiology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
出版信息
Am J Transplant. 2021 Sep;21(9):3208-3209. doi: 10.1111/ajt.16629. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Kidney transplant with positive SARS-CoV-2 PCR: An avoidable risk.严重急性呼吸综合征冠状病毒2型聚合酶链反应（SARS-CoV-2 PCR）检测呈阳性的肾移植：一种可避免的风险。
Am J Transplant. 2021 Sep;21(9):3208-3209. doi: 10.1111/ajt.16629. Epub 2021 May 24.
2
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.COVID-19 患者肾移植受者中存活的 SARS-CoV-2 的长期脱落。
Am J Transplant. 2021 Aug;21(8):2871-2875. doi: 10.1111/ajt.16636. Epub 2021 Jun 18.
3
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
4
Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?康复后重复进行新冠病毒2型检测。移植前是否需要进行PCR检测？
Am J Transplant. 2021 Sep;21(9):3206-3207. doi: 10.1111/ajt.16506. Epub 2021 Feb 18.
5
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。
Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
6
Negative COVID-19 Plasma PCR Following COVID-19+ Donor Kidney Transplant.新冠病毒阳性供体肾移植后新冠病毒血浆聚合酶链反应结果为阴性
Transplantation. 2022 Sep 1;106(9):e422-e423. doi: 10.1097/TP.0000000000004204. Epub 2022 Jun 1.
7
Protecting kidney transplant recipients against SARS-CoV-2 infection: A third dose of vaccine is necessary now.保护肾移植受者免受SARS-CoV-2感染：现在需要接种第三剂疫苗。
Am J Transplant. 2022 Apr;22(4):1275-1276. doi: 10.1111/ajt.16829. Epub 2021 Sep 7.
8
Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.接种疫苗后时代肝、肾移植受者中 SARS-CoV-2 感染的发生率和严重程度：来自丹麦的真实数据。
Am J Transplant. 2022 Nov;22(11):2637-2650. doi: 10.1111/ajt.17141. Epub 2022 Jul 26.
9
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在肾移植受者中的持续存在情况。
Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.
10
True effect of monoclonal antibody for COVID-19 in kidney transplant recipients.单克隆抗体对肾移植受者治疗新冠肺炎的真实疗效
Am J Transplant. 2022 May;22(5):1492-1493. doi: 10.1111/ajt.16922. Epub 2021 Dec 18.
本文引用的文献
1
SARS-CoV-2 infection on the kidney transplant waiting list: Can a patient be transplanted after COVID-19?肾移植等待名单上的新型冠状病毒2感染：新冠肺炎康复后的患者能否进行移植？
Nefrologia (Engl Ed). 2022 Mar-Apr;42(2):215-217. doi: 10.1016/j.nefroe.2022.04.003. Epub 2022 Apr 18.
2
Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?康复后重复进行新冠病毒2型检测。移植前是否需要进行PCR检测？
Am J Transplant. 2021 Sep;21(9):3206-3207. doi: 10.1111/ajt.16506. Epub 2021 Feb 18.
3
Ct value is not enough to discriminate patients harbouring infective virus.新冠病毒核酸检测的Ct值不足以区分携带感染性病毒的患者。
J Infect. 2021 Mar;82(3):e35-e37. doi: 10.1016/j.jinf.2020.11.025. Epub 2020 Nov 26.
4
COVID-19 in transplant recipients: The Spanish experience.器官移植受者中的 COVID-19：西班牙经验。
Am J Transplant. 2021 May;21(5):1825-1837. doi: 10.1111/ajt.16369. Epub 2020 Nov 10.
5
Successful orthotopic liver transplantation in a patient with a positive SARS-CoV2 test and acute liver failure secondary to acetaminophen overdose.成功进行了一例正接受 SARS-CoV2 检测的患者的原位肝移植，该患者因乙酰氨基酚过量导致急性肝衰竭。
Am J Transplant. 2021 Mar;21(3):1312-1316. doi: 10.1111/ajt.16330. Epub 2020 Oct 23.
Zotero 插件